mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.004 |
mRNA |
ruxolitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.098 |
0.005 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.005 |
mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.005 |
mRNA |
PIK-93 |
GDSC1000 |
pan-cancer |
AAC |
0.079 |
0.006 |
mRNA |
XMD14-99 |
GDSC1000 |
pan-cancer |
AAC |
0.09 |
0.006 |
mRNA |
FK866 |
GDSC1000 |
pan-cancer |
AAC |
0.083 |
0.006 |
mRNA |
PI-103 |
GDSC1000 |
pan-cancer |
AAC |
0.082 |
0.007 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.008 |
mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.008 |